Skip to content

ARTBIO vs CIS Pharma

ARTBIO logo

ARTBIO

Channeling Energy. Changing Lives

74 employees · est. 2021 · Cambridge, United States

VS
CIS Pharma logo

CIS Pharma

Innovation made in Switzerland

5 employees · est. 1952 · Switzerland

CIS Pharma is the older company (2021 vs 1952); ARTBIO is the larger of the two.

Side-by-Side Comparison

ARTBIO CIS Pharma
Founded
2021 1952 older
Headquarters
Cambridge, United States Switzerland
Employees
74 larger 5
Industry
Biotechnology, Health Care, Medical Devices Biotechnology, Fashion, Life Sciences
Funding Stage
Series B Not tracked yet
Total Funding
$245.00M Not tracked yet
Funding Rounds
3 Not tracked yet
Services
Development of Alpha Radioligand Therapies, Clinical Research and Trials, Manufacturing Ecosystem for Therapy Solutions Not tracked yet
Target Customers
Cancer Patients, Oncologists, Healthcare Providers Not tracked yet
Taxonomy
Alpha Radioligand TherapiesRadiopharmaceuticalsClinical-stageCancer CarePrecision MedicinePb-212 Isotope Technology +6 BiopharmaceuticalCancer TreatmentImmunotherapyNext-generation DrugsTargeted TherapiesRadioligand Therapy +7
Website
artbio.com cis-pharma.com
ARTBIO logo

About ARTBIO

ARTBIO, founded in 2021 and based in the United States, is pioneering a paradigm shift in cancer treatment. Their focus on developing Alpha Radioligand Therapies (ARTs) leverages unique Pb-212 isotope technology, aiming to offer transformative solutions in oncology. The company’s mantra, “Channeling...

CIS Pharma logo

About CIS Pharma

CIS Pharma is a biopharmaceutical company based in the Basel Area, Switzerland. Specializing in the development of next-gen immuno-conjugates, ADCs, and radioligand treatments, the company targets cancer patients with poor prognosis and a high spread of metastases. With assets including two targetin...

Also comparing in this category

Comparing more than these two?

Get ARTBIO, CIS Pharma and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does ARTBIO compare?

A PDF of ARTBIO and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

ARTBIO was founded in 2021, based in Cambridge, United States, with 74 employees. ARTBIO, founded in 2021 and based in the United States, is pioneering a paradigm shift in cancer treatment. Their focus on developing Alpha Radioligand Therapies (ARTs) leverages unique Pb-212 isotope. CIS Pharma was founded in 1952, based in Switzerland, with 5 employees. CIS Pharma is a biopharmaceutical company based in the Basel Area, Switzerland. Specializing in the development of next-gen immuno-conjugates, ADCs, and radioligand treatments, the company targets can.
ARTBIO has raised $245.00M and CIS Pharma no disclosed funding. Latest stage: ARTBIO Series B.
Both work in Biotechnology, Medical Devices and Pharmaceutical and list precision medicine among their focus areas.

Compare ARTBIO with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at ARTBIO on 9 Jun 2026, and CIS Pharma on 13 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout